Mer receptor tyrosine kinase is a therapeutic target in pre–B-cell acute lymphoblastic leukemia
Supplemental materials for: Linger et al
Files in this Data Supplement:
Document 1. Supplemental methods, tables, and figures (PDF, 183 KB)